|
|
| (One intermediate revision not shown.) |
| Line 3: |
Line 3: |
| | <StructureSection load='5tnj' size='340' side='right'caption='[[5tnj]], [[Resolution|resolution]] 1.65Å' scene=''> | | <StructureSection load='5tnj' size='340' side='right'caption='[[5tnj]], [[Resolution|resolution]] 1.65Å' scene=''> |
| | == Structural highlights == | | == Structural highlights == |
| - | <table><tr><td colspan='2'>[[5tnj]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Pseab Pseab]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5TNJ OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5TNJ FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[5tnj]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Pseudomonas_aeruginosa_UCBPP-PA14 Pseudomonas aeruginosa UCBPP-PA14]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5TNJ OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5TNJ FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=8MD:(1S,2S,4S)-4-ethenylcyclohexane-1,2-diol'>8MD</scene>, <scene name='pdbligand=AVH:(1R,2R,4R)-4-ethenylcyclohexane-1,2-diol'>AVH</scene>, <scene name='pdbligand=BVH:(1R,2R,4S)-4-ethenylcyclohexane-1,2-diol'>BVH</scene>, <scene name='pdbligand=DVH:(1S,2S,4R)-4-ethenylcyclohexane-1,2-diol'>DVH</scene></td></tr> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.65Å</td></tr> |
| - | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[3kd2|3kd2]], [[4dmc|4dmc]], [[5tnd|5tnd]], [[5tnf|5tnf]], [[5tng|5tng]], [[5tnh|5tnh]], [[5tni|5tni]], [[5tnk|5tnk]], [[5tnl|5tnl]], [[5tnm|5tnm]], [[5tnn|5tnn]], [[5tnp|5tnp]], [[5tnq|5tnq]], [[5tnr|5tnr]], [[5tns|5tns]]</td></tr>
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=8MD:(2~{S},4~{S})-4-ethenylcyclohexane-1,2-diol'>8MD</scene>, <scene name='pdbligand=AVH:(1R,2R,4R)-4-ethenylcyclohexane-1,2-diol'>AVH</scene>, <scene name='pdbligand=BVH:(1~{R},2~{R},4~{S})-4-ethenylcyclohexane-1,2-diol'>BVH</scene>, <scene name='pdbligand=DVH:(1S,2S,4R)-4-ethenylcyclohexane-1,2-diol'>DVH</scene></td></tr> |
| - | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">PA14_26090 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=208963 PSEAB])</td></tr>
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5tnj FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5tnj OCA], [https://pdbe.org/5tnj PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5tnj RCSB], [https://www.ebi.ac.uk/pdbsum/5tnj PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5tnj ProSAT]</span></td></tr> |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5tnj FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5tnj OCA], [http://pdbe.org/5tnj PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5tnj RCSB], [http://www.ebi.ac.uk/pdbsum/5tnj PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5tnj ProSAT]</span></td></tr> | + | |
| | </table> | | </table> |
| | + | == Function == |
| | + | [https://www.uniprot.org/uniprot/A0A0H2ZD27_PSEAB A0A0H2ZD27_PSEAB] |
| | <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
| | == Publication Abstract from PubMed == | | == Publication Abstract from PubMed == |
| Line 18: |
Line 19: |
| | </div> | | </div> |
| | <div class="pdbe-citations 5tnj" style="background-color:#fffaf0;"></div> | | <div class="pdbe-citations 5tnj" style="background-color:#fffaf0;"></div> |
| | + | |
| | + | ==See Also== |
| | + | *[[CFTR inhibitory factor|CFTR inhibitory factor]] |
| | == References == | | == References == |
| | <references/> | | <references/> |
| Line 23: |
Line 27: |
| | </StructureSection> | | </StructureSection> |
| | [[Category: Large Structures]] | | [[Category: Large Structures]] |
| - | [[Category: Pseab]] | + | [[Category: Pseudomonas aeruginosa UCBPP-PA14]] |
| - | [[Category: Hvorecny, K L]] | + | [[Category: Hvorecny KL]] |
| - | [[Category: Madden, D R]] | + | [[Category: Madden DR]] |
| - | [[Category: Epoxide hydrolase]]
| + | |
| - | [[Category: Hydrolase]]
| + | |
| - | [[Category: Hydroxyalkyl-enzyme intermediate]]
| + | |
| Structural highlights
Function
A0A0H2ZD27_PSEAB
Publication Abstract from PubMed
Pseudomonas aeruginosa secretes an epoxide hydrolase with catalytic activity that triggers degradation of the cystic fibrosis transmembrane conductance regulator (CFTR) and perturbs other host defense networks. Targets of this CFTR inhibitory factor (Cif) are largely unknown, but include an epoxy-fatty acid. In this class of signaling molecules, chirality can be an important determinant of physiological output and potency. Here we explore the active-site chemistry of this two-step alpha/beta-hydrolase and its implications for an emerging class of virulence enzymes. In combination with hydrolysis data, crystal structures of 15 trapped hydroxyalkyl-enzyme intermediates reveal the stereochemical basis of Cif's substrate specificity, as well as its regioisomeric and enantiomeric preferences. The structures also reveal distinct sets of conformational changes that enable the active site to expand dramatically in two directions, accommodating a surprising array of potential physiological epoxide targets. These new substrates may contribute to Cif's diverse effects in vivo, and thus to the success of P. aeruginosa and other pathogens during infection.
Active-Site Flexibility and Substrate Specificity in a Bacterial Virulence Factor: Crystallographic Snapshots of an Epoxide Hydrolase.,Hvorecny KL, Bahl CD, Kitamura S, Lee KSS, Hammock BD, Morisseau C, Madden DR Structure. 2017 May 2;25(5):697-707.e4. doi: 10.1016/j.str.2017.03.002. Epub 2017, Apr 6. PMID:28392259[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
See Also
References
- ↑ Hvorecny KL, Bahl CD, Kitamura S, Lee KSS, Hammock BD, Morisseau C, Madden DR. Active-Site Flexibility and Substrate Specificity in a Bacterial Virulence Factor: Crystallographic Snapshots of an Epoxide Hydrolase. Structure. 2017 May 2;25(5):697-707.e4. doi: 10.1016/j.str.2017.03.002. Epub 2017, Apr 6. PMID:28392259 doi:http://dx.doi.org/10.1016/j.str.2017.03.002
|
